EZH2-mediated methylation has been demonstrated to repress T helper 1 (Th1) chemokines, CXCL9 and CXCL10, resulting in reduced T-cell recruitment to the tumor microenvironment [41]. This evidence concerns the gene CXCL10 and neoplasm.